Company news
GlycoNex, Inc. news in 2025
GlycoNex, Inc.'s news releases, calls and decks from 2025, newest first.
GlycoNex Signs CDMO Service Agreement with Change Cure to Advance HMGB1-Targeted Antibody Program
December 8, 2025
GlycoNex and Hokkaido University Hospital Launch Study to Advance Glycan-Directed ADC Development in Gastric Cancer
November 24, 2025
GlycoNex Announces Last Patient Dosed in Phase 3 Trial of SPD8, a Denosumab Biosimilar for Osteoporosis
October 29, 2025
GlycoNex Abstract on Glycan-Directed ADC GNX1021 Accepted for Presentation at AACR-NCI-EORTC 2025
October 20, 2025
GlycoNex to Participate in BIO Asia-Taiwan 2025
July 21, 2025